Today: 17 May 2026
U.S. Mortgage Rates Rise Above 6% Again, Threatening Spring Homebuying Revival
13 March 2026
2 mins read

U.S. Mortgage Rates Rise Above 6% Again, Threatening Spring Homebuying Revival

WASHINGTON, March 13, 2026, 06:36 EDT

  • The average 30-year fixed mortgage from Freddie Mac jumped to 6.11%, up from 6.00%. That’s the sharpest weekly climb since April 2025.
  • February existing-home sales picked up 1.7%, while mortgage applications climbed 3.2%—both hinting at movement in the market.
  • Oil prices and Treasury yields, both climbing on war concerns with Iran, are stirring inflation fears right as the spring housing season approaches.

Mortgage rates in the U.S. climbed back over 6% this week, snapping a short-lived drop below that threshold and logging their sharpest weekly jump in nearly a year. Rising oil prices and surging bond yields—spurred by the conflict with Iran—sent the average 30-year fixed rate up to 6.11%, compared with 6.00% just a week ago, according to Freddie Mac on Thursday.

This shift landed right when cheaper borrowing was starting to lure buyers off the sidelines for spring. Existing-home sales climbed 1.7% in February, reaching a 4.09 million annual rate. First-time buyers accounted for 34% of deals. Mortgage applications ticked up 3.2% for the week ending March 6—purchase applications jumped 7.8%.

Just two weeks back, the 30-year mortgage rate slipped to 5.98%—marking its first dip below the 6% threshold since September 2022. That break mattered, with economists framing it as a key psychological trigger for both buyers and sellers. Now, an 11 basis-point jump this week, or 0.11 percentage point, lands with more impact.

Mortgage rates typically shadow the 10-year Treasury yield, which hovered near 4.25% on Thursday, ticking up from roughly 4.13% the week before. A spike in oil—prices raced toward $100 after Iranian attacks on tankers—rekindled inflation worries and triggered a bond selloff, sending home-loan costs higher.

Freddie Mac chief economist Sam Khater noted the 30-year mortgage rate has “returned to last month’s level” at 6.11%, but pointed out buyers remain sensitive to rates in this territory. The 15-year fixed, a popular pick among homeowners refinancing, edged up to 5.50% from 5.43%. freddiemac.com

“Normally, softer labor and inflation data would help bring down mortgage rates,” said Hannah Jones, senior economic research analyst at Realtor.com. “But right now, headlines from the Middle East are pushing past those trends.” In February, unemployment edged up to 4.4%, payrolls dropped by 92,000, and consumer inflation stuck at 2.4%. Even so, markets pushed rates higher, pricing in renewed energy-driven inflation risks. Realtor

Mike Fratantoni, chief economist at the Mortgage Bankers Association, echoed that point. “Financial markets were volatile,” he noted last week. MBA data had the average contract rate for a 30-year loan within federal limits climbing to 6.19%, up from 6.09%. Even so, total purchase volume landed 10% ahead of where it was a year ago. MBA Newslink

Zillow Home Loans had 30-year fixed loans at 6.125% on Friday. Redfin reported new listings up 0.5% year over year, with sellers banking that rates around 6%—not 7%—might lure buyers again.

The market’s still unsteady. Since 2023, existing-home sales have barely budged from a roughly 4 million annual rate—far off the 5.2 million mark that’s more typical. February inventory came in at just 1.29 million homes, translating to a 3.8-month supply, according to NAR. That setup leaves mortgage rates likely stuck north of 6% and threatens to sap momentum from any early spring bounce, especially if oil prices and Treasury yields keep climbing. Lawrence Yun, chief economist at the National Association of Realtors, called housing affordability “improving,” but flagged stubbornly slow inventory gains. AP News

Stock Market Today

  • XRP Price Declines Amid Bearish Pressure Near $1.50 Resistance
    May 17, 2026, 5:46 AM EDT. Ripple's XRP is sliding, currently testing support at $1.43. The cryptocurrency faces significant selling pressure near $1.50, which has restricted gains since Monday. This resistance zone is acting as a ceiling, triggering bearish movements and weighing on XRP's short-term outlook.

Latest articles

E-Power Stock Drops Again: Why EPOW’s 66-Cent Close Sets Up a Tense Week

E-Power Stock Drops Again: Why EPOW’s 66-Cent Close Sets Up a Tense Week

17 May 2026
E-Power Inc. shares closed at $0.66 Friday, down 7.04%, after its annual report showed a 28.59% drop in net revenue to $46.4 million and a widened net loss of $26.66 million, citing “substantial doubt” about its ability to continue as a going concern. The Nasdaq Composite also fell 1.54% Friday, ending a six-week rally. E-Power announced new patents and a $252 million microgrid project earlier in the week.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.05.2026

17 May 2026
LIVEMarkets rolling coverageStarted: May 17, 2026, 4:00 AM EDTUpdated: May 17, 2026, 5:54 AM EDT XRP Price Declines Amid Bearish Pressure Near $1.50 Resistance May 17, 2026, 5:46 AM EDT. Ripple’s XRP is sliding, currently testing support at $1.43. The cryptocurrency faces significant selling pressure near $1.50, which has restricted gains since Monday. This resistance zone is acting as a ceiling, triggering bearish movements and weighing on XRP’s short-term outlook. Why is XRP falling? INFRONEER Holdings' New Stock Grant Trust and Governance Shift Impact Investment Outlook May 17, 2026, 5:45 AM EDT. INFRONEER Holdings Inc. (TSE:5076) reported fiscal 2026 results
Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Grab Holdings Stock Price Falls 3% as CEO Share Sale Filing Adds Pressure
Previous Story

Grab Holdings Stock Price Falls 3% as CEO Share Sale Filing Adds Pressure

Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59
Next Story

Occidental Petroleum Stock in Focus as $100 Oil Pushes OXY to $59

Go toTop